ATC/DDD

ATC/DDD index H05BX

You are here: Home > ATC/DDD > H > H05 > H05B

- ATC/DDD
Anatomical therapeutic chemical (ATC) classification system
- H
SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
- H05
CALCIUM HOMEOSTASIS
- H05B
ANTI-PARATHYROID AGENTS

H05BX

Other anti-parathyroid agents

ATC/DDD code H05BX for Other anti-parathyroid agents

Paricalcitol and doxercalciferol indicated for the prevention and treatment of secondary hyperparathyroidism are classified here.

The DDD for cinacalcet is based on the treatment of secondary hyperparathyroidism.

H05BX01
cinacalcet
H05BX02
paricalcitol
H05BX03
doxercalciferol
ICD-10
ATC
ICD-10 International Statistical Classification of Diseases and Related Health Problems 10th Revision
ICD-10

ICD-10 is the 10th revision of the International Statistical Classification of Diseases and Related Health Problems (ICD), a medical classification list by the World Health Organization (WHO).

It contains codes for diseases, signs and symptoms, abnormal findings, complaints, social circumstances, and external causes of injury or diseases.

ATC

The Anatomical Therapeutic Chemical (ATC) Classification System is used for the classification of active ingredients of drugs according to the organ or system on which they act and their therapeutic, pharmacological and chemical properties.

It is controlled by the World Health Organization Collaborating Centre for Drug Statistics Methodology (WHOCC).

DDD

The defined daily dose (DDD) is a statistical measure of drug consumption, defined by the World Health Organization (WHO).

It is used to standardize the comparison of drug usage between different drugs or between different health care environments.

Home Contact Us